Dave Ahern's avatar
$4.6m follower assets
Experts Expectations For Continued Diabetes Growth ($NVO)
Experts expect diabetes to continue to grow over the next 20+ years and while that sucks on a personal level, it does provide an opportunity for pharma to help lessen the impacts.

$NVO stands to benefit from the increases in diabetes with Ozempic and Wegovy over the next few years.

Image upload
Joshua Simka's avatar
Stunning chart. It would be interesting to see a breakdown by country.
Dissecting the Markets's avatar
I read that Ozempic isn't a type of insulin nor a substitute for it. Do you see any firms creating an alternative to insulin, especially as a insulin shortage looms.



Already have an account?